Literature DB >> 27103170

Why we should understand the patient experience: clinical empathy and medicines optimisation.

Barry Jubraj1, Nina L Barnett2, Lesley Grimes3, Sneha Varia4, Angel Chater5, Vivian Auyeung6.   

Abstract

OBJECTIVES: To critically discuss the need for pharmacists to underpin their consultations with appropriate 'clinical empathy' as part of effective medicines optimisation.
METHODS: Use of literature around empathy, consultation and pharmacy practice to develop a case for greater clinical empathy in pharmacy consultations. KEY
FINDINGS: Clinical empathy is defined from the literature and applied to pharmacy consultations, with a comparison to empathy in other clinical professions. Historical barriers to the embedding of clinical empathy into pharmacy consultations are also explored.
CONCLUSIONS: We challenge the pharmacy profession to consider how clinical empathy should underpin consultations with a series of introspective questions and provide some sample questions to support pharmacy consultations. We also make the case for appropriate education and professional development of consultation skills at undergraduate and postgraduate level. We contend that patients' relationships with practitioners are critical, and a lack of empathy can impact the effectiveness of care.
© 2016 Royal Pharmaceutical Society.

Entities:  

Keywords:  clinical empathy; patient experience; pharmacists

Mesh:

Year:  2016        PMID: 27103170     DOI: 10.1111/ijpp.12268

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  7 in total

1.  Comparing Empathy Levels in Doctor of Pharmacy Students and Exemplary Pharmacist Preceptors.

Authors:  Charlene R Williams; Philip T Rodgers; Jacqueline E McLaughlin; Thomas A Angelo; Greene Shepherd
Journal:  Am J Pharm Educ       Date:  2020-03       Impact factor: 2.047

2.  Equipping community pharmacy workers as agents for health behaviour change: developing and testing a theory-based smoking cessation intervention.

Authors:  Liz Steed; Ratna Sohanpal; Wai-Yee James; Carol Rivas; Sandra Jumbe; Angel Chater; Adam Todd; Elizabeth Edwards; Virginia Macneil; Fraser Macfarlane; Trisha Greenhalgh; Chris Griffiths; Sandra Eldridge; Stephanie Taylor; Robert Walton
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

3.  Theory-based electronic learning intervention to support appropriate antibiotic prescribing by nurse and pharmacist independent prescribers: an acceptability and feasibility experimental study using mixed methods.

Authors:  Rosemary Lim; Molly Courtenay; Rhian Deslandes; Rebecca Ferriday; David Gillespie; Karen Hodson; Nicholas Reid; Neil Thomas; Angel Chater
Journal:  BMJ Open       Date:  2020-06-30       Impact factor: 2.692

4.  Effects of Patients' Perceptions of Physician-Patient Relational Empathy on an Inflammation Marker in Patients with Crohn's Disease: The Intermediary Roles of Anxiety, Self-Efficacy, and Sleep Quality.

Authors:  Xianlin Xu; Yan Zhang; Wei Wang; Yin Zhang; Ningxi Yang
Journal:  Psychol Res Behav Manag       Date:  2020-04-29

5.  Mediating Roles of Anxiety, Self-Efficacy, and Sleep Quality on the Relationship Between Patient-Reported Physician Empathy and Inflammatory Markers in Ulcerative Colitis Patients.

Authors:  Xiangfan Chen; Yin Zhang; Xianlin Xu; Wei Wang; Hong Yan; Shiyue Li; Ningxi Yang
Journal:  Med Sci Monit       Date:  2019-10-21

6.  A randomised controlled trial of energetic activity for depression in young people (READY): a multi-site feasibility trial protocol.

Authors:  N Howlett; L Bottoms; A Chater; A B Clark; T Clarke; L David; K Irvine; A Jones; J Jones; S E Mengoni; J Murdoch; M Pond; S Sharma; E J Sims; D A Turner; D Wellsted; J Wilson; S Wyatt; D Trivedi
Journal:  Pilot Feasibility Stud       Date:  2021-01-04

7.  An Exploratory Mixed Methods Study of Standardized Patient Comments on Empathy and Student Communication Scores.

Authors:  Logan T Murry; Jeffrey C Reist; Michelle A Fravel; Laura E Knockel; Mathew J Witry
Journal:  Am J Pharm Educ       Date:  2021-07-22       Impact factor: 2.047

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.